Figure 2From: Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice Mammary tumor onset in MTB-IGFIR, MTB-IGFIR/Akt1 -/- and MTB-IGFIR/Akt2 -/- mice. The graph shows mammary tumor onset in MTB-IGFIR/Akt1-/- mice (red line; n=6), MTB-IGFIR/Akt2-/- mice (green line; n=6) and MTB-IGFIR mice (black line; n=11). The same group of MTB-IGFIR mice were used for both comparisons.Back to article page